Correlation of urine sFlt-1/PLGF ratio with abnormal trophoblast invasion and apoptosis in pregnant women with preeclampsia

Correlation of urine sFlt-1/PLGF ratio with abnormal trophoblast invasion and apoptosis in pregnant women with preeclampsia

Objective: To investigate the correlation of urine sFlt-1/PLGF ratio with abnormal trophoblast invasion and apoptosis in pregnant women with preeclampsia. Methods: A total of 183 healthy second-trimester pregnant women who received antenatal care in this hospital between December 2015 and Decembe...

Full description

Bibliographic Details
Main Authors:	Xi-Ping Hong, Jie Xi
Format:	Article
Language:	English
Published:	Editorial Board of Journal of Hainan Medical University 2018-07-01
Series:	Journal of Hainan Medical University
Subjects:	Preeclampsia sFlt-1/PLGF ratio Invasion Apoptosis
Online Access:	http://www.hnykdxxb.com/PDF/201814/14.pdf

Similar Items

sFlt-1, PlGF, sFlt-1/PlGF ratio and uterine artery Doppler for preeclampsia diagnostics
by: Viktorija Tarasevičienė, et al.
Published: (2016-01-01)

Zusammenhang zwischen angiogenen Faktoren (sFlt-1/PlGF-Ratio) und klinischen Parametern des Schwangerschaftsausgangs bei manifesten hypertensiven Schwangerschaftserkrankungen
by: Tauscher, Anne
Published: (2013)

A cross sectional study to assess the sFlt-1:PlGF ratio in pregnant women with and without preeclampsia
by: Vivek Pant, et al.
Published: (2019-07-01)

sFlt-1, Not PlGF, Is Related to Twin Gestation Choronicity in the First and Third Trimesters of Pregnancy
by: Szymon Kozłowski, et al.
Published: (2021-06-01)

Die Wertigkeit des sFlt-1/PlGF-Quotienten als Prädiktionsmarker bei Schwangeren mit erhöhtem Präeklampsierisiko
by: Husse, Sorina
Published: (2017)

Prospektive Evaluierung von sFlt-1, PlGF und sEndoglin als prognostische Marker für die Entwicklung einer Präeklampsie bei Schwangerschaften mit uteriner Perfusionsstörung im 2. Trimenon
by: Schwarz, Friederike
Published: (2013)

Die Wertigkeit des sFlt-1/PlGF-Quotienten als Prädiktionsmarker bei Schwangeren mit erhöhtem Präeklampsierisiko
by: Husse, Sorina Ines
Published: (2015)

Study on sEng, VEGF, PLGF, and sFlt-1 levels, and umbilical artery blood flow change in the pregnant women with preeclampsia
by: Xia Liu
Published: (2016-04-01)

Angiogenesis-Related Biomarkers (sFlt-1/PLGF) in the Prediction and Diagnosis of Placental Dysfunction: An Approach for Clinical Integration
by: Ignacio Herraiz, et al.
Published: (2015-08-01)

Effect of Low-Dose Aspirin on Soluble FMS-Like Tyrosine Kinase 1/Placental Growth Factor (sFlt-1/PlGF Ratio) in Pregnancies at High Risk for the Development of Preeclampsia
by: Karoline Mayer-Pickel, et al.
Published: (2019-09-01)

sFlt-1/PlGF Ratio in Prediction of Short-Term Neonatal Outcome of Small for Gestational Age Neonates
by: Jacek Witwicki, et al.
Published: (2021-08-01)

Trophoblast-Targeted Nanomedicine Modulates Placental sFLT1 for Preeclampsia Treatment
by: Lei Li, et al.
Published: (2020-02-01)

The umbilical cord, preeclampsia and the VEGF family
by: Olaya-C M, et al.
Published: (2018-11-01)

Pro-angiogenic therapeutics for preeclampsia
by: Adrian C. Eddy, et al.
Published: (2018-08-01)

Diagnostic Accuracy of Different Soluble fms-Like Tyrosine Kinase 1 and Placental Growth Factor Cut-Off Values in the Assessment of Preterm and Term Preeclampsia: A Gestational Age Matched Case-Control Study
by: Evelyn A. Huhn, et al.
Published: (2018-11-01)

Analysis of Methyldopa Therapy on sFlt-1 Antiangiogenic Levels in Patients with Severe Preeclampsia
by: Teri Wina Herwati, et al.
Published: (2018-04-01)

Activation of PAR-1/NADPH Oxidase/ROS Signaling Pathways is Crucial for the Thrombin-Induced sFlt-1 Production in Extravillous Trophoblasts: Possible Involvement in the Pathogenesis of Preeclampsia
by: Qi-tao Huang, et al.
Published: (2015-03-01)

Angiogenic factors and the risk of preeclampsia: A systematic review and meta-analysis
by: Yousef Veisani, et al.
Published: (2019-01-01)

Intraperitoneal Injection of High Tumor Necrosis Factor (TNF- α ) Serum Increase Soluble Fms-like Tyrosine Kinase 1 (sFlt-1) and Blood Pressure of Pregnant Mice
by: Bramantyo Aji Wicaksono, et al.
Published: (2015-05-01)

Enhanced Serum Levels of sFlt1: Impact on Materno–Fetal CMV Transmission
by: Lukas Penka, et al.
Published: (2020-04-01)

CORRELATION BETWEEN FMS-LIKE TYROSINE KINASE-1 (SFLT-1) CELL-FREE MESSENGER RNA EXPRESSION AND FMS-LIKE TYROSINE KINASE-1 (SFLT-1) PROTEIN LEVEL IN SEVERE PREECLAMPSIA AND NORMAL PREGNANCY
by: Jeffry Iman Gurnadi, et al.
Published: (2015-09-01)

MZe786 Rescues Cardiac Mitochondrial Activity in High sFlt-1 and Low HO-1 Environment
by: Lissette Carolina Sanchez-Aranguren, et al.
Published: (2020-07-01)

Circulating Levels of sFlt1 Splice Variants as Predictive Markers for the Development of Preeclampsia
by: Colby A. Souders, et al.
Published: (2015-06-01)

Unfractionated heparin displaces sFlt-1 from the placental extracellular matrix
by: Kyle H. Moore, et al.
Published: (2020-06-01)

Potential use of sFlt-1 and pterin to predict the clinical outcome of cardiovascular disease.
by: Marks, Edward Charles Arthur
Published: (2015)

Regulation of angiogenic and anti-angiogenic gene expression in human trophoblast
by: Ismaeel, Haneen Moayad
Published: (2018)

Perbandingan Kadar Soluble Fms-Like Tyrosine Kinase 1 (SFLT1) Serum Kehamilan Normal dengan Preeklamsi Berat Serta Hubungannya dengan Tekanan Darah dan Derajat Proteinuria
by: Amillia Siddiq, et al.
Published: (2009-09-01)

MZe786, a hydrogen sulfide-releasing aspirin prevents preeclampsia in heme oxygenase-1 haplodeficient pregnancy under high soluble flt-1 environment
by: Homira Rezai, et al.
Published: (2021-01-01)

Human Placental NADPH Oxidase Mediates sFlt-1 and PlGF Secretion in Early Pregnancy: Exploration of the TGF-β1/p38 MAPK Pathways
by: Isabelle Hernandez, et al.
Published: (2021-02-01)

Production of an anti-angiogenic factor sFLT1 is suppressed via promoter hypermethylation of FLT1 gene in choriocarcinoma cells
by: Tadashi Sasagawa, et al.
Published: (2020-02-01)

High Level of Soluble FMS-Like Tyrosine Kinase-1 (sFlt-1) Serum in Pregnancy as a Risk Factor of Preeclampsia
by: I Gede Mega Putra, et al.
Published: (2016-07-01)

Placental Abnormalities and Preeclampsia in Trisomy 13 Pregnancies
by: Chih-Ping Chen
Published: (2009-03-01)

Reduced fetal movement intervention Trial-2 (ReMIT-2): protocol for a pilot randomised controlled trial of standard care informed by the result of a placental growth factor (PlGF) blood test versus standard care alone in women presenting with reduced fetal movement at or after 36+ 0 weeks gestation
by: Lindsay Armstrong-Buisseret, et al.
Published: (2018-10-01)

PlGF Immunological Impact during Pregnancy
by: Loredana Albonici, et al.
Published: (2020-11-01)

sFLT01 modulates invasion and metastasis in prostate cancer DU145 cells by inhibition of VEGF/GRP78/MMP2&9 axis
by: Sepideh Taghizadeh, et al.
Published: (2021-05-01)

Serum placental growth factor and soluble fms-like tyrosine kinase-1 in preeclamptic women at their third trimester of pregnancy
by: Nesreen Nasser, et al.
Published: (2020-12-01)

Apium graveolens Prevents Intrauterine Growth Restriction via Suppression of Antiangiogenic Factor Production
by: Exma Mu'tatal Hikmah, et al.
Published: (2018-08-01)

PREPARE: protocol for a stepped wedge trial to evaluate whether a risk stratification model can reduce preterm deliveries among women with suspected or confirmed preterm pre-eclampsia
by: Marcos Augusto Bastos Dias, et al.
Published: (2019-10-01)

Human sFLT1 Leads to Severe Changes in Placental Differentiation and Vascularization in a Transgenic hsFLT1/rtTA FGR Mouse Model
by: Rebekka Vogtmann, et al.
Published: (2019-03-01)

Inhibitory Effect of Eicosapentaenoic Acid (EPA) on sFlt-1 (Soluble VEGF Receptor-1) Expression in Trophoblast Tumor Cell Line JEG-3
by: F Zare, et al.
Published: (2013-04-01)